“PSMA-PET Registry for Recurrent Prostate Cancer”
This study aims to institute a province-wide registry leveraging the availability of a new Positron Emission Tomography tracer, [18F]-DCFPyL and PET expertise across Ontario centers to improve our ability to characterize patterns of recurrence and personalize therapies in men with recurrent prostate cancer after primary treatment.
Diagnostic Test - [18F]-DCFPyL PET/ CT scan (PSMA PET)
Participants will undergo re-staging with [18F]-DCFPyL PET/CT Scan (PSMA PET).
PSMA-PET Registry for Recurrent Prostate Cancer